Tech Company Inital Public Offerings

T2 Biosystems IPO

T2 Biosystems was acquired by . The company's stock became public on 8/7/2014.

Transaction Overview

Company Name
Announced On
8/7/2014
Transaction Type
IPO
Amount
$57,200,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
101 Hartwell Ave.
Lexington, MA 02421
USA
Email Address
Overview
T2 Biosystems (NASDAQ: TTOO) is a diagnostics company ushering in a new wave of innovative products to improve medical decision-making and treatment. Our proprietary biosensor technology was invented by a team of world-renowned scientists at MIT and Massachusetts General Hospital.
Profile
T2 Biosystems LinkedIn Company Profile
Social Media
T2 Biosystems Company Twitter Account
Company News
T2 Biosystems News
Facebook
T2 Biosystems on Facebook
YouTube
T2 Biosystems on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John McDonough
  John McDonough LinkedIn Profile  John McDonough Twitter Account  John McDonough News  John McDonough on Facebook
Chief Financial Officer
John Sprague
  John Sprague LinkedIn Profile  John Sprague Twitter Account  John Sprague News  John Sprague on Facebook
Chief Scientific Officer
Thomas Lowery
  Thomas Lowery LinkedIn Profile  Thomas Lowery Twitter Account  Thomas Lowery News  Thomas Lowery on Facebook
VP - General Counsel
Michael Gibbs
  Michael Gibbs LinkedIn Profile  Michael Gibbs Twitter Account  Michael Gibbs News  Michael Gibbs on Facebook
VP - Human Resources
Kelley Morgan
  Kelley Morgan LinkedIn Profile  Kelley Morgan Twitter Account  Kelley Morgan News  Kelley Morgan on Facebook
VP - Operations
Alec Barclay
  Alec Barclay LinkedIn Profile  Alec Barclay Twitter Account  Alec Barclay News  Alec Barclay on Facebook
VP - Regulatory Affairs
Sandy Estrada
  Sandy Estrada LinkedIn Profile  Sandy Estrada Twitter Account  Sandy Estrada News  Sandy Estrada on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/7/2014: Zephyrus Biosciences venture capital transaction
Next: 8/7/2014: Lifetime Oil venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary